• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L. 叶提取物通过调节高脂喂养的C57BL/6小鼠的AMPK途径改善代谢功能障碍相关脂肪性肝病。

L. Leaf Extract Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating the AMPK Pathway in High Fat-Fed C57BL/6 Mice.

作者信息

Gu Min Ji, Ahn Yejin, Lee Yu Ra, Yoo Guijae, Kim Yoonsook, Choi Inwook, Ha Sang Keun, Kim Donghwan

机构信息

Korea Food Research Institute, Wanju-gun 55365, Republic of Korea.

Division of Food Biotechnology, University of Science and Technology, Daejeon 34113, Republic of Korea.

出版信息

Nutrients. 2024 Nov 30;16(23):4165. doi: 10.3390/nu16234165.

DOI:10.3390/nu16234165
PMID:39683561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11644762/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. In recent times, the term NAFLD has been modified to metabolic dysfunction-associated steatotic liver disease (MASLD), reflecting its comprehensive scope encompassing a range of metabolic abnormalities. L. (CS) is a traditional medicine, although the preventive mechanism of CS extracts remains unclear.

OBJECTIVE

This study evaluated the preventive effects of CS in high-fat diet (HFD)-induced MASLD mice by oral administration of 100 or 200 mg/kg/day of CS extracts for 12 weeks.

RESULTS

The major CS extract compounds were chlorogenic acid, caffeic acid, rutin, and isoquercetin. The administration of CS extract suppressed HFD-induced weight gain, liver weight, and the liver/body weight ratio. It improved the mice's serum biological profiles and suppressed HFD-induced lipid droplet and lipid accumulation by inhibiting lipid accumulation-related gene expression in the liver. It modulated HFD-induced Ampk-Srebp1c pathways and suppressed HFD-induced NF-κB pathway activation in the liver. It regulated inflammation and the AMPK alpha signaling pathway in HFD-fed mice by reducing the accumulation of specific amino acids, leading to the amelioration of fatty liver.

CONCLUSIONS

The CS extract prevents HFD-induced MASLD and may help prevent or treat MASLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病。近年来,NAFLD这一术语已被修改为代谢功能障碍相关脂肪性肝病(MASLD),反映了其涵盖一系列代谢异常的全面范畴。杜仲(CS)是一种传统药物,但其提取物的预防机制尚不清楚。

目的

本研究通过对高脂饮食(HFD)诱导的MASLD小鼠口服给予100或200 mg/kg/天的CS提取物,持续12周,评估CS的预防作用。

结果

CS提取物的主要化合物为绿原酸、咖啡酸、芦丁和异槲皮苷。给予CS提取物可抑制HFD诱导的体重增加、肝脏重量及肝/体重比。它改善了小鼠的血清生物学指标,并通过抑制肝脏中脂质积累相关基因的表达,抑制了HFD诱导的脂滴和脂质积累。它调节了HFD诱导的Ampk-Srebp1c信号通路,并抑制了HFD诱导的肝脏中NF-κB信号通路的激活。它通过减少特定氨基酸的积累来调节HFD喂养小鼠的炎症和AMPKα信号通路,从而改善脂肪肝。

结论

CS提取物可预防HFD诱导的MASLD,可能有助于预防或治疗MASLD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/b80f36f546d5/nutrients-16-04165-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/6ac8d74add9b/nutrients-16-04165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/3601801e9ae4/nutrients-16-04165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/4fbac0e807a9/nutrients-16-04165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/7489808aa0cf/nutrients-16-04165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/7c772f2692a2/nutrients-16-04165-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/71f03a1b85b9/nutrients-16-04165-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/7584341739f1/nutrients-16-04165-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/828e858dc843/nutrients-16-04165-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/b80f36f546d5/nutrients-16-04165-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/6ac8d74add9b/nutrients-16-04165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/3601801e9ae4/nutrients-16-04165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/4fbac0e807a9/nutrients-16-04165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/7489808aa0cf/nutrients-16-04165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/7c772f2692a2/nutrients-16-04165-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/71f03a1b85b9/nutrients-16-04165-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/7584341739f1/nutrients-16-04165-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/828e858dc843/nutrients-16-04165-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c91/11644762/b80f36f546d5/nutrients-16-04165-g009.jpg

相似文献

1
L. Leaf Extract Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating the AMPK Pathway in High Fat-Fed C57BL/6 Mice.L. 叶提取物通过调节高脂喂养的C57BL/6小鼠的AMPK途径改善代谢功能障碍相关脂肪性肝病。
Nutrients. 2024 Nov 30;16(23):4165. doi: 10.3390/nu16234165.
2
Alpha-aminobutyric acid ameliorates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) progression in mice via enhancing AMPK/SIRT1 pathway and modulating the gut-liver axis.α-氨基丁酸通过增强AMPK/SIRT1通路和调节肠-肝轴改善饮食诱导的代谢功能障碍相关脂肪性肝病(MASLD)在小鼠中的进展。
J Nutr Biochem. 2025 Jun;140:109885. doi: 10.1016/j.jnutbio.2025.109885. Epub 2025 Feb 25.
3
Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.补骨脂提取物可改善游离脂肪酸孵育的 HepG2 细胞和高脂饮食喂养小鼠的非酒精性脂肪性肝病。
J Food Sci. 2020 Jul;85(7):2216-2226. doi: 10.1111/1750-3841.15166. Epub 2020 Jun 24.
4
Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease the Sirt1/AMPK and NF-κB signaling pathways.丙烯基异硫氰酸酯通过 Sirt1/AMPK 和 NF-κB 信号通路改善非酒精性脂肪性肝病中的脂质积累和炎症。
World J Gastroenterol. 2019 Sep 14;25(34):5120-5133. doi: 10.3748/wjg.v25.i34.5120.
5
The Extract of Camellia Seed Cake Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Mice by Promoting Coenzyme Q Synthesis.茶籽饼提取物通过促进辅酶Q合成减轻小鼠代谢功能障碍相关脂肪性肝病(MASLD)
Nutrients. 2025 Mar 15;17(6):1032. doi: 10.3390/nu17061032.
6
Polyoxometalates Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease by Activating the AMPK Signaling Pathway.多金属氧酸盐通过激活 AMPK 信号通路改善代谢相关脂肪性肝病的肝功能障碍。
Int J Nanomedicine. 2024 Oct 25;19:10839-10856. doi: 10.2147/IJN.S485084. eCollection 2024.
7
Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.消脂方通过激活AMPK和PPAR通路调节脂质代谢,从而减轻非酒精性脂肪性肝病。
J Ethnopharmacol. 2024 Jul 15;329:118165. doi: 10.1016/j.jep.2024.118165. Epub 2024 Apr 7.
8
Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1.咖啡酸通过靶向 Keap1 激活 Nrf2 减轻肝细胞氧化损伤和脂质堆积来改善代谢相关脂肪性肝病。
Free Radic Biol Med. 2024 Nov 1;224:352-365. doi: 10.1016/j.freeradbiomed.2024.08.038. Epub 2024 Aug 28.
9
Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice.菊苣酸通过AMPK/Nrf2/NFB信号通路改善高脂饮食喂养小鼠的非酒精性脂肪性肝病并恢复肠道微生物群。
Oxid Med Cell Longev. 2020 Nov 3;2020:9734560. doi: 10.1155/2020/9734560. eCollection 2020.
10
subsp. CKDB001 Ameliorates Metabolic Complications in High-Fat Diet-Induced Obese Mice.亚种CKDB001改善高脂饮食诱导的肥胖小鼠的代谢并发症。
Nutrients. 2024 Dec 10;16(24):4260. doi: 10.3390/nu16244260.

引用本文的文献

1
A Plant-Based Strategy for MASLD: (Thunb.) DC. Extract Reduces Hepatic Lipid Accumulation and Improves Glycogen Storage In Vitro and In Vivo.一种用于代谢相关脂肪性肝病的植物性策略:(拇指)DC提取物可减少肝脏脂质积累并在体外和体内改善糖原储存
Int J Mol Sci. 2025 Aug 30;26(17):8442. doi: 10.3390/ijms26178442.
2
Milpa Diet for MASLD in Mesoamerican Populations: Feasibility, Advantages, and Future Perspectives.中美洲人群中用于非酒精性脂肪性肝炎相关脂肪性肝病的米尔帕饮食:可行性、优势及未来展望
Life (Basel). 2025 May 19;15(5):812. doi: 10.3390/life15050812.

本文引用的文献

1
Food inequity and insecurity and MASLD: burden, challenges, and interventions.食物不平等和不安全与 MASLD:负担、挑战和干预。
Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):668-686. doi: 10.1038/s41575-024-00959-4. Epub 2024 Jul 29.
2
Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions.揭开非酒精性脂肪性肝炎的复杂性:代谢、转运体和草药-药物相互作用的作用。
Life Sci. 2024 Aug 15;351:122806. doi: 10.1016/j.lfs.2024.122806. Epub 2024 Jun 7.
3
The protective effects of some herbs on mitigating HFD-induced obesity via enhancing biochemical indicators and fertility in female rats.
某些草药通过提高生化指标和雌性大鼠生育能力对减轻高脂饮食诱导的肥胖的保护作用。
Heliyon. 2024 May 1;10(9):e30249. doi: 10.1016/j.heliyon.2024.e30249. eCollection 2024 May 15.
4
Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology.代谢相关脂肪性肝病:终期术语演变。
Eur J Intern Med. 2024 Jun;124:35-39. doi: 10.1016/j.ejim.2024.04.013. Epub 2024 Apr 22.
5
Evolving liver disease insights from NAFLD to MASLD.从非酒精性脂肪性肝病到代谢相关性脂肪性肝病的肝脏疾病进展见解。
Trends Endocrinol Metab. 2024 Aug;35(8):683-686. doi: 10.1016/j.tem.2024.02.012. Epub 2024 Feb 29.
6
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.一项评估 Resmetirom 治疗伴有肝纤维化的 NASH 的 3 期随机对照试验。
N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000.
7
Exploration of neuroprotective effect from Coriandrum sativum L. ethanolic seeds extracts on brain of obese rats.芫荽籽醇提物对肥胖大鼠大脑的神经保护作用研究。
Sci Rep. 2024 Jan 5;14(1):603. doi: 10.1038/s41598-024-51221-5.
8
Protective effects of chlorogenic acid against cyclophosphamide induced liver injury in mice.绿原酸对环磷酰胺诱导的小鼠肝损伤的保护作用。
Biotech Histochem. 2024 Nov;99(1):33-43. doi: 10.1080/10520295.2023.2287452. Epub 2024 Jan 9.
9
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
10
Dietary Isoquercetin Reduces Hepatic Cholesterol and Triglyceride in NAFLD Mice by Modulating Bile Acid Metabolism via Intestinal FXR-FGF15 Signaling.饮食中的异槲皮素通过肠道 FXR-FGF15 信号调节胆汁酸代谢来降低 NAFLD 小鼠的肝胆固醇和甘油三酯。
J Agric Food Chem. 2023 May 24;71(20):7723-7733. doi: 10.1021/acs.jafc.3c00952. Epub 2023 May 11.